Eli Lilly and Company (NYSE: LLY) today announced a three-year extension of its cancer research collaboration with Dana-Farber Cancer Institute ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE